CanLiv Research Symposium

Thank you to everyone who joined CanLiv for the 3rd annual CanLiv Research Symposium. Check back soon for video clips and watch the archived event below.

View slide from the 2013 Symposium:

Empowering Precision Medicine Without Boundaries by Markus Warmuth MD, CEO of H3 Biomedicine Inc.
Translating the Cancer Genome Into New Therapeutics by Peter Smith PhD, Executive Director Drug Discovery Biology, H3 Biomedicine Inc. & TransPoC (Translational Preclinical Oncology
Consortium)

Also, check out videos from our 2012 conference below.

Dr. Melanie Thomas: CanLiv Foundation
Dr. Jesper Andersen: Genome Basic for Targeted Therapies in Cholangiocarcinoma
Margaret Anderson: Creating a Successful Research Consortium
Dr. John Niederhuber: Accelerating Therapeutic Advances in Biliary & Gallbladder Cancers
Dr. Juan Carlos Roa: Molecular Pathology of Gallbladder Cancer
Dr. Lewis Roberts: Recent Results from Genetic Profiling of Cholangiocarcinoma: IDH Gene Mutations in Intraheptic Cholangiocarcinoma
Dr. Kenna Shaw: TCGA: A Community Resource Looking for a Community
Dr. Abby Siegel and Dr. Anthony El-Khoueiry: Treatment of Biliary Cancers
Dr. Al Sirica: Fibroblasts, Cell Signaling Pathways in Cholangiocarcinoma
Dr. Xin Wei Wang: Genetic Alterations and Stem Cell Progenitors in Cholangiocarinoma

For regular updates on the event, check our Facebook page.

Last Updated on 5/15/2013 10:59:21 AM

CanLiv Research Symposium

Contact Us

Join Our Community